We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rare Childhood Liver Disease Traced to Defective Lipid Metabolism Gene

By LabMedica International staff writers
Posted on 20 Sep 2012
A team of Israeli and Canadian geneticists has used advanced genomic research tools to identify a mutation responsible for a rare inherited childhood fatty liver syndrome.

A group of 10 children and infants from a single Israeli Arab village were found to have enlarged livers, high levels of blood fats, and irregular liver function. More...
In more technical terms, these individuals manifested a moderate to severe transient childhood hypertriglyceridemia and fatty liver followed by hepatic fibrosis.

To discover the mutation that linked these cases investigators at Schneider Children's Medical Center (Tel Aviv, Israel) and their colleagues at the University of Western Ontario (London, Canada) performed SNP (single-nucleotide polymorphism) array-based homozygosity mapping of DNA samples obtained from the patient group.

They reported in the January 2012 issue of the American Journal of Human Genetics that they had found a single large continuous segment of homozygosity on chromosomal region 12q13.12. The candidate region contained 35 genes that were listed in Online Mendelian Inheritance in Man (OMIM) and 27 other genes. OMIM is a comprehensive, authoritative, and timely compendium of human genes and genetic phenotypes maintained on the Internet by Johns Hopkins University (Baltimore, MD, USA). The full-text, referenced overviews in OMIM contain information on all known Mendelian disorders and over 12,000 genes. OMIM focuses on the relationship between phenotype and genotype.

The investigators then performed candidate gene sequencing and screened both clinically affected individuals (children and adults with hypertriglyceridemia) and also a healthy cohort for mutations in the GPD1gene, which encodes glycerol-3-phosphate dehydrogenase 1. Results revealed a homozygous splicing mutation, which resulted in an aberrantly spliced mRNA in the 10 affected individuals. This mutation predicted the synthesis of a truncated protein lacking essential conserved residues, including a functional site responsible for initial substrate recognition.

Prevalence of the mutation in the village was thought to be due to a high marriage rate between first cousins. Introduction of genetic counseling could reduce the number of babies born with the defective gene.

Related Links:

Schneider Children's Medical Center
University of Western Ontario
Johns Hopkins University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
POC Immunoassay Analyzer
Procise DX
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.